inositol has been researched along with phenylalanine in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 7 (35.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Ding, HF; Lang, L; Liu, G; Sun, SY; Yan, C | 1 |
| Bitar, K; Reinhold, JG | 1 |
| Byer, M; Chadwick, P; Delisle, GJ | 1 |
| Iwashima, A; Kawasaki, T; Nakamura, M; Nose, Y | 1 |
| Costa, T; Nose, T; Ogino, Y; Ohno, M; Shimizu, N; Shimohigashi, Y | 1 |
| Akiyoshi, M; Fujitani, S; Ikenoue, T; Kondo, N; Maki, T; Okazaki, K; Tsuchiya, Y | 1 |
| Becker, K; Brodde, OE; Heinroth-Hoffmann, I; Pönicke, K | 1 |
| Kawamori, R; Kitahara, Y; Mine, T; Miura, K; Okano, A | 1 |
| Yamada, K | 1 |
| Kitahara, Y; Miura, K; Mori, Y; Tajima, N | 1 |
| Ishida, H; Kadowaki, T; Kawamori, R | 1 |
| Hirose, T; Kawamori, R; Kawasumi, M; Kurebayashi, S; Tanaka, Y; Watada, H | 1 |
| Best, M; Ferrieri, RA; Koenig, K; McDonald, K; Rogers, A; Schueller, M | 1 |
| Kataoka, Y; Kimura, K; Kosuge, M; Miyamoto, Y; Miyazaki, S; Sase, K; Yasuda, S; Yoshimasa, Y | 2 |
| Masuzaki, H; Sata, M; Shimabukuro, M | 1 |
| Adams, M; Kondo, E; Kouremenos, KA; Marriott, PJ; Morrison, P; Parker, RM | 1 |
| Fukase, H; Harigai, M; Iida, S; Ikeda, S; Kasahara, N; Miyata, K; Ohba, Y; Saito, T; Takano, Y; Terao, K | 1 |
| Huang, J; Wu, J; Xian, C; Yuan, Q | 1 |
| Abdel-Hamid, AZ; El-Maraghy, SA; Hanafy, MM; Lindeque, JZ; Shahin, NN | 1 |
1 review(s) available for inositol and phenylalanine
| Article | Year |
|---|---|
[Pharmacological treatment of postprandial hyperglycemia in hypertensive patients with type 2 diabetes mellitus].
Topics: Acarbose; Cyclohexanes; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypertension; Hypoglycemic Agents; Inositol; Insulin Resistance; Nateglinide; Obesity; Phenylalanine; Postprandial Period | 2003 |
3 trial(s) available for inositol and phenylalanine
| Article | Year |
|---|---|
Efficacy and adverse effects of nateglinide in early type 2 diabetes. Comparison with voglibose in a cross-over study.
Topics: Aged; alpha-Glucosidases; Appetite; Body Weight; Cross-Over Studies; Cyclohexanes; Diabetes Mellitus, Type 2; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Gastrointestinal Tract; Glycated Hemoglobin; Humans; Hypoglycemia; Inositol; Lipids; Liver Function Tests; Male; Middle Aged; Nateglinide; Phenylalanine; Treatment Outcome | 2006 |
Effects of voglibose and nateglinide on glycemic status and coronary atherosclerosis in early-stage diabetic patients.
Topics: Aged; Coronary Artery Disease; Cyclohexanes; Diabetes Complications; Diabetes Mellitus; Female; Glycemic Index; Humans; Hypoglycemic Agents; Inositol; Male; Middle Aged; Nateglinide; Phenylalanine | 2012 |
A Pharmacokinetic/Pharmacodynamic Drug-Drug Interaction Study of Tofogliflozin (a New SGLT2 Inhibitor) and Selected Anti-Type 2 Diabetes Mellitus Drugs.
Topics: 1-Deoxynojirimycin; Adult; Benzhydryl Compounds; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Interactions; Glucose; Glucosides; Healthy Volunteers; Humans; Hypoglycemic Agents; Inositol; Male; Metformin; Middle Aged; Nateglinide; Phenylalanine; Pioglitazone; Sitagliptin Phosphate; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Thiazolidinediones; Urine; Young Adult | 2016 |
16 other study(ies) available for inositol and phenylalanine
| Article | Year |
|---|---|
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
Topics: CRISPR-Cas Systems; Gene Targeting; Genes; Genes, Reporter; Genetic Engineering; Humans; Internal Ribosome Entry Sites; Transcription, Genetic | 2015 |
Phytase and alkaline phosphatase activities in intestinal mucosae of rat, chicken, calf, and man.
Topics: 6-Phytase; Alkaline Phosphatase; Ammonium Sulfate; Animals; Butanols; Cattle; Chickens; Chromatography, DEAE-Cellulose; Edetic Acid; Fluorides; Hot Temperature; Humans; Hydrogen-Ion Concentration; Inositol; Intestinal Mucosa; Intestine, Small; Kinetics; Phenylalanine; Rats; Species Specificity; Structure-Activity Relationship; Zinc | 1972 |
Biochemical identification of hospital enterobacteria by replica agar plating.
Topics: Agar; Bacteriological Techniques; Citrates; Colistin; Deamination; Decarboxylation; Drug Resistance, Microbial; Enterobacteriaceae; Esculin; Evaluation Studies as Topic; Fermentation; Hydrolysis; Indoles; Inositol; Lysine; Ornithine; Phenylalanine; Species Specificity | 1974 |
Effect of amino acids and purine bases on thiamine synthesis by Escherichia coli.
Topics: Adenine; Amino Acids; Aspartic Acid; Culture Media; Cystine; Cytosine; Escherichia coli; Glutamates; Glycine; Guanine; Histidine; Hypoxanthines; Inositol; Isoleucine; Leucine; Methionine; Phenylalanine; Proline; Purines; Serine; Thiamine; Thiazoles; Threonine; Thymine; Tyrosine; Uracil; Valine | 1968 |
Enhancement of thrombin receptor activation by thrombin receptor-derived heptapeptide with para-fluorophenylalanine in place of phenylalanine.
Topics: Amino Acid Sequence; Animals; Cell Line; Circular Dichroism; Epithelium; Indicators and Reagents; Inositol; Kinetics; Molecular Sequence Data; p-Fluorophenylalanine; Peptide Fragments; Phenylalanine; Phosphatidylinositols; Receptors, Cell Surface; Receptors, Thrombin; Structure-Activity Relationship; Thrombin | 1993 |
Effect of a new hypoglycemic agent, A-4166 [(-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine], on postprandial blood glucose excursion: comparison with voglibose and glibenclamide.
Topics: Animals; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Glucose; Glyburide; Hypoglycemic Agents; Inositol; Insulin; Male; Nateglinide; Phenylalanine; Postprandial Period; Rats; Rats, Wistar; Sucrose | 1997 |
Trophic effect of angiotensin II in neonatal rat cardiomyocytes: role of endothelin-1 and non-myocyte cells.
Topics: Angiotensin II; Animals; Animals, Newborn; Anti-Arrhythmia Agents; Biphenyl Compounds; Cell Adhesion; Cells, Cultured; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-3; Endothelins; GTP-Binding Proteins; Heart; Imidazoles; Inositol; Inositol Phosphates; Isotope Labeling; Losartan; Myocardium; Peptide Fragments; Peptides, Cyclic; Pertussis Toxin; Phenylalanine; Rats; Rats, Wistar; Tetrazoles; Vasoconstrictor Agents; Virulence Factors, Bordetella | 1997 |
Nateglinide suppresses postprandial hypertriglyceridemia in Zucker fatty rats and Goto-Kakizaki rats: comparison with voglibose and glibenclamide.
Topics: Animals; Blood Glucose; Cyclohexanes; Glyburide; Hypertriglyceridemia; Inositol; Male; Nateglinide; Phenylalanine; Postprandial Period; Rats; Rats, Wistar; Rats, Zucker; Species Specificity | 2002 |
Comparison of voglibose and nateglinide for their acute effects on insulin secretion and free fatty acid levels in OLETF rat portal blood after sucrose loading.
Topics: Animals; Area Under Curve; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Disease Models, Animal; Enzyme Inhibitors; Fatty Acids, Nonesterified; Hypoglycemic Agents; Inositol; Insulin; Insulin Secretion; Male; Nateglinide; Phenylalanine; Portal Vein; Postprandial Period; Rats; Rats, Inbred OLETF; Secretory Rate; Sucrose | 2004 |
[Achieving better control of blood sugar--understanding of oral hypoglycemic agents according to their characteristics in pharmacological action mechanism (discussion)].
Topics: Administration, Oral; Cardiovascular Diseases; Cyclohexanes; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combination; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Indoles; Inositol; Insulin; Insulin Resistance; Insulin Secretion; Isoindoles; Nateglinide; Phenylalanine; Risk Factors; Stimulation, Chemical; Sulfonylurea Compounds; Thiazolidinediones | 2004 |
Inhibition of trehalose breakdown increases new carbon partitioning into cellulosic biomass in Nicotiana tabacum.
Topics: Biomass; Carbon; Carbon Dioxide; Carbon Radioisotopes; Cellulose; Enzyme Activation; Inositol; Lignin; Nicotiana; Phenylalanine; Phenylalanine Ammonia-Lyase; Polysaccharides; Trehalase; Trehalose | 2011 |
Intensive glucose lowering in cardiovascular risk management - unsolved questions - .
Topics: Coronary Artery Disease; Cyclohexanes; Diabetes Mellitus; Female; Glycemic Index; Humans; Inositol; Male; Nateglinide; Phenylalanine | 2012 |
Metabolic profiling of yeast culture using gas chromatography coupled with orthogonal acceleration accurate mass time-of-flight mass spectrometry: application to biomarker discovery.
Topics: Biomarkers; Discriminant Analysis; Gas Chromatography-Mass Spectrometry; Inositol; Least-Squares Analysis; Liquid-Liquid Extraction; Metabolome; Microwaves; Phenylalanine; Principal Component Analysis; Ribose; Saccharomyces cerevisiae | 2014 |
Clinical predictors of atheroma progression despite optimal glycemic control in early-stage diabetic patients with coronary artery disease: Insight from the DIANA study.
Topics: Blood Glucose; Coronary Angiography; Coronary Artery Disease; Cyclohexanes; Diabetes Mellitus; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inositol; Life Style; Male; Middle Aged; Nateglinide; Phenylalanine; Plaque, Atherosclerotic; Prospective Studies; Risk Factors; Ultrasonography, Interventional | 2014 |
Amino Acid- and Growth Factor-Based Multifunctional Nanocapsules for the Modulation of the Local Microenvironment in Tissue Engineering.
Topics: Amino Acids; Animals; Anti-Inflammatory Agents; Antioxidants; Arginine; Human Umbilical Vein Endothelial Cells; Humans; Inositol; Intercellular Signaling Peptides and Proteins; Male; Mice; Nanocapsules; NIH 3T3 Cells; Phenylalanine; Polyesters; Rats, Sprague-Dawley; RAW 264.7 Cells; Reactive Oxygen Species; Tissue Engineering; Vitamin E; Wound Healing | 2021 |
Time-based investigation of urinary metabolic markers for Type 2 diabetes: Metabolomics approach for diabetes management.
Topics: Animals; Biomarkers; Carnitine; Cluster Analysis; Deoxyglucose; Diabetes Mellitus, Experimental; Disease Progression; Fructose; Fucose; Galactose; Glycosuria; Inositol; Magnetic Resonance Spectroscopy; Male; Metabolome; Metabolomics; Phenylalanine; Rats; Rats, Wistar; Streptozocin; Taurine; Time Factors | 2021 |